Simplex Trading’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-53,200
| Closed | -$986K | – | 10228 |
|
|
2023
Q3 | $986K | Sell |
53,200
-54,200
| -50% | -$613K | ﹤0.01% | 2677 |
|
|
2023
Q2 | $1.19M | Sell |
107,400
-8,100
| -7% | -$113K | ﹤0.01% | 2441 |
|
|
2023
Q1 | $1.55M | Buy |
115,500
+10,400
| +10% | +$180K | ﹤0.01% | 2167 |
|
|
2022
Q4 | $1.3M | Sell |
105,100
-9,400
| -8% | -$133K | ﹤0.01% | 2221 |
|
|
2022
Q3 | $1.6M | Buy |
114,500
+98,000
| +594% | +$1.58M | ﹤0.01% | 2169 |
|
|
2022
Q2 | $227K | Sell |
16,500
-125,800
| -88% | -$2.01M | ﹤0.01% | 4458 |
|
|
2022
Q1 | $2.31M | Buy |
142,300
+77,700
| +120% | +$1.22M | ﹤0.01% | 1954 |
|
|
2021
Q4 | $1.05M | Buy |
64,600
+37,100
| +135% | +$625K | ﹤0.01% | 2790 |
|
|
2021
Q3 | $562K | Hold |
27,500
| – | – | ﹤0.01% | 3904 |
|
|
2021
Q2 | $549K | Buy |
27,500
+27,311
| +14,450% | +$541K | ﹤0.01% | 4010 |
|
|
2021
Q1 | $436K | Sell |
189
-89
| -32% | -$2.48K | ﹤0.01% | 3566 |
|
|
2020
Q4 | $686K | Buy |
278
+131
| +89% | +$4.34K | ﹤0.01% | 3040 |
|
|
2020
Q3 | $609K | Sell |
147
-299
| -67% | -$13.7K | ﹤0.01% | 2772 |
|
|
2020
Q2 | $2.14M | Sell |
446
-159
| -26% | -$12.3K | ﹤0.01% | 1455 |
|
|
2020
Q1 | $3.81M | Sell |
605
-203
| -25% | -$18.2K | 0.01% | 846 |
|
|
2019
Q4 | $10M | Buy |
808
+453
| +128% | +$40.6K | 0.02% | 466 |
|
|
2019
Q3 | $2.35M | Buy |
355
+79
| +29% | +$5.3K | 0.01% | 1209 |
|
|
2019
Q2 | $2.2M | Sell |
276
-537
| -66% | -$48.1K | 0.01% | 1237 |
|
|
2019
Q1 | $9.09M | Buy |
813
+245
| +43% | +$26.8K | 0.03% | 421 |
|
|
2018
Q4 | $5.72M | Buy |
568
+235
| +71% | +$24.4K | 0.02% | 509 |
|
|
2018
Q3 | $4.21M | Buy |
333
+211
| +173% | +$22.3K | 0.01% | 718 |
|
|
2018
Q2 | $1.02M | Buy |
122
+58
| +91% | +$4.25K | ﹤0.01% | 1771 |
|
|
2018
Q1 | $49K | Sell |
64
-214
| -77% | -$12.9K | ﹤0.01% | 2470 |
|
|
2017
Q4 | $1.07M | Sell |
278
-185
| -40% | -$11.7K | 0.05% | 373 |
|
|
2017
Q3 | $1.45M | Buy |
463
+183
| +65% | +$19.7K | 0.06% | 263 |
|
|
2017
Q2 | $195K | Sell |
280
-7
| -2% | -$811 | 0.01% | 1221 |
|
|
2017
Q1 | $191K | Sell |
287
-271
| -49% | -$31.6K | 0.01% | 1246 |
|
|
2016
Q4 | $745K | Buy |
558
+306
| +121% | +$36.5K | 0.04% | 359 |
|
|
2016
Q3 | $259K | Buy |
252
+12
| +5% | +$1.89K | 0.02% | 862 |
|
|
2016
Q2 | $442K | Buy |
240
+32
| +15% | +$4.67K | 0.03% | 578 |
|
|
2016
Q1 | $230K | Buy |
208
+124
| +148% | +$14.6K | 0.02% | 802 |
|
|
2015
Q4 | $318K | Buy |
84
+15
| +22% | +$2.54K | 0.02% | 614 |
|
|
2015
Q3 | $821K | Sell |
69
-48
| -41% | -$10.6K | 0.06% | 285 |
|
|
2015
Q2 | $712K | Sell |
117
-34
| -23% | -$9.05K | 0.06% | 303 |
|
|
2015
Q1 | $292K | Buy |
151
+57
| +61% | +$12.3K | 0.03% | 543 |
|
|
2014
Q4 | $504K | Buy |
+94
| New | +$17.4K | 0.06% | 271 |
|
Simplex Trading's ICPT Position: Q4 2023 in Review
Simplex Trading sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 1,384 shares — an estimated $25K sold.
Simplex Trading first reported a position in ICPT in Q1 2015 and held it in 25 quarters. The position peaked at $2.35M in Q2 2016. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- Simplex Trading reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Simplex Trading sold 1,384 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $25K.
- Simplex Trading first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2015 and held it in 25 quarters.
- Simplex Trading's Intercept Pharmaceuticals, Inc. position peaked at $2.35M in Q2 2016.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on Simplex Trading's 13F filing for Q4 2023, filed 2 Feb 2024.